A POWERFUL APPROACH TO NASAL AIRWAY OBSTRUCTION
Address the multiple sources of nasal airway obstruction using the minimally invasive VivAer® Stylus

VivAer Stylus Treats the Multiple Sources of Nasal Airway Obstruction in a Single Procedure
VivAer Stylus allows you to address multiple key factors contributing to nasal airway obstruction with one procedure, offering long-lasting results:
- Durably remodels nasal cartilage and soft tissue
- A single treatment solution to:
- Open the nasal airway by targeting nasal valve obstruction
- Reduce submucosal tissue in the inferior turbinate
- Shrink soft tissue obstructions in the septal swell body
Innovative, Office-friendly Technology with Proven Symptom Relief
The Aerin® Console and the VivAer Stylus are compact and portable, designed to seamlessly integrate into any clinic, office, or hospital environment. VivAer Stylus is a convenient and efficient treatment option for seamless integration into your practice.
The VivAer Stylus, with its low-profile design, leverages temperature-controlled radiofrequency (RF) technology specifically optimized for the nasal airway. Once positioned, the VivAer Stylus tip precisely maintains the therapeutic temperature to effectively remodel tissue while minimizing impact on surrounding areas.

Endorsement by the American Academy of Otolaryngology
Head and Neck Surgery of surgical repair of the nasal valve as a distinct surtical procedure to improve nasal obstruction symptoms:

“The nasal valve may be stabilized using office-based treatments, such as implants or radiofrequency treatment. For patients who require anatomic widening and definitive stabilization of the nasal valve, surgical treatment of nasal valve collapse, along with treatment of other possible causes of nasal airway obstruction, is required to optimize patient outcomes. Failure to perform nasal valve repair, when indicated, is a common cause of incomplete symptom resolution for patients with nasal obstruction and nasal valve dysfunction.”1-5
AAO-HNSF, March 2023
Disclaimer
The VivAer® Stylus is indicated for use in otorhinolaryngology (ENT) surgery for the coagulation of soft tissue in the nasal airway, to treat nasal airway obstruction by shrinking submucosal tissue, including cartilage in the internal nasal valve area.
Specific indications, contraindications, warnings, precautions, and safety information exist for these products. Aerin Medical relies on the physician to determine, assess and communicate to each patient all foreseeable risks of the procedure. A physician must always refer to the package insert, product label and/or instructions for use before using any of Aerin Medical’s products. Rx only.
Current Procedural Terminology (CPT) Copyright 2025 American Medical Association (AMA). All rights reserved. CPT® is a registered trademark of the American Medical Association.
References:
- Stewart M, Ferguson B, Fromer L. Epidemiology and burden of nasal congestion. Int J Gen Med. 2010 Apr 8;3:37-45. doi: 10.2147/ijgm.s8077. PMID: 20463822; PMCID: PMC2866547.
- Clark D, et al., Nasal airway obstruction: Prevalence and anatomic contributors. Ear Nose Throat J. 2018 June;97(6):173-176.
- Data on file. Aerin quantitative NOSE Score Survey. Apr 2021
- Pedersen L, et al. (2023) A comparison of men and women undergoing septoplasty—the Swedish national septoplasty register. Front. Surg. 10:1223607. doi: 10.3389/fsurg.2023.1223607
- Payne et al. Medical therapy versus sinus surgery by using balloon sinus dilation technology: A prospective multicenter study. Am J Rhinol Allergy 30, 279–286, 2016; doi: 10.2500/ajra.2016.30.4346.
WEB1322-32.A